FANJ
INFI

Financial Architects (New Jersey)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Financial Architects (New Jersey)’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,000
Closed -$22K – 980
2015
Q2 		$22K Sell
2,000
-2,000
-50% -$25.7K 0.01% 626
2015
Q1 		$56K Hold
4,000
– – 0.02% 385
2014
Q4 		$68K Hold
4,000
– – 0.03% 308
2014
Q3 		$54K Hold
4,000
– – 0.03% 302
2014
Q2 		$51K Buy
+4,000
New +$41.7K 0.02% 316

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Financial Architects (New Jersey)'s INFI Position: Q3 2015 in Review

Financial Architects (New Jersey) sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2015, closing a stake of 2,000 shares — an estimated $22K sold.

Financial Architects (New Jersey) first reported a position in INFI in Q2 2014 and held it in 5 quarters. The position peaked at $68K in Q4 2014. 129 funds tracked by Wall St. Rank hold INFI as of Q3 2015.

  • Financial Architects (New Jersey) reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 2,000 Infinity Pharmaceuticals, Inc. shares in Q3 2015, an estimated $22K.
  • Financial Architects (New Jersey) first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2014 and held it in 5 quarters.
  • Financial Architects (New Jersey)'s Infinity Pharmaceuticals, Inc. position peaked at $68K in Q4 2014.
  • 129 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2015.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2015, filed 13 Nov 2015.